Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Outcome of adult acute lymphoblastic leukaemia following induction chemotherapy with modified MRC UKALL XII/ECOG E2993 protocol.

Islam N, Rahman MM, Aziz MA, Begum F, Yunus AB.

Bangladesh Med Res Counc Bull. 2012 Aug;38(2):43-6.

PMID:
23227626
3.

Induction therapy using the MRC UKALLXII/ECOG E2993 protocol in Chinese adults with acute lymphoblastic leukemia.

Wang H, Chen XQ, Geng QR, Liu PP, Lin GN, Xia ZJ, Lu Y.

Int J Hematol. 2011 Aug;94(2):163-8. doi: 10.1007/s12185-011-0891-y. Epub 2011 Jul 6.

PMID:
21732037
4.

Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993.

Rowe JM, Buck G, Burnett AK, Chopra R, Wiernik PH, Richards SM, Lazarus HM, Franklin IM, Litzow MR, Ciobanu N, Prentice HG, Durrant J, Tallman MS, Goldstone AH; ECOG; MRC/NCRI Adult Leukemia Working Party.

Blood. 2005 Dec 1;106(12):3760-7. Epub 2005 Aug 16.

5.
6.

Outcome of adult acute lymphoblastic leukemia with BFM protocol in a resource-constrained setting.

Malhotra P, Varma S, Varma N, Kumari S, Das R, Jain S, Ahluwalia J, Mahi S, Sharma SC, Radhika S.

Leuk Lymphoma. 2007 Jun;48(6):1173-8.

PMID:
17577781
7.

Long-term survival in acute lymphoblastic leukaemia in adults treated according to the LALA 87 protocol.

Colović M, Bogdanović A, Janković G, Kraguljac N, Suvajdzić N.

Chemotherapy. 2003 Jun;49(3):138-45.

PMID:
12815207
8.

Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.

Tzortzatou-Stathopoulou F, Papadopoulou AL, Moschovi M, Botsonis A, Tsangaris GT.

J Pediatr Hematol Oncol. 2001 Dec;23(9):591-7. Review.

PMID:
11902303
9.

High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group.

Yanada M, Takeuchi J, Sugiura I, Akiyama H, Usui N, Yagasaki F, Kobayashi T, Ueda Y, Takeuchi M, Miyawaki S, Maruta A, Emi N, Miyazaki Y, Ohtake S, Jinnai I, Matsuo K, Naoe T, Ohno R; Japan Adult Leukemia Study Group.

J Clin Oncol. 2006 Jan 20;24(3):460-6. Epub 2005 Dec 12.

PMID:
16344315
10.

Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.

Azuma T, Tobinai K, Takeyama K, Shibata T, Hidaka M, Kurosawa M, Kasai M, Chou T, Fukushima N, Mukai K, Tsukasaki K, Shimoyama M; Japan Clinical Oncology Group-Lymphoma Study Group (JCOG-LSG), Tokyo, Japan.

Jpn J Clin Oncol. 2012 May;42(5):394-404. doi: 10.1093/jjco/hys029. Epub 2012 Mar 15.

PMID:
22422899
11.

Induction-consolidation with an idarubicin-containing regimen, unpurged marrow autograft, and post-graft chemotherapy in adult acute lymphoblastic leukaemia.

Bassan R, Lerede T, Di Bona E, Rambaldi A, Rossi G, Pogliani E, Oriani A, D'Emilio A, Izzi T, Lambertenghi-Deliliers G, Corneo G, Barbui T.

Br J Haematol. 1999 Mar;104(4):755-62.

PMID:
10192437
13.

[Acute lymphoblastic leukemia: experience in adult patients treated with hyperCVAD and 0195 Protocol, at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Cohort 2003-2007].

Arteaga-Ortiz L, Buitrón-Santiago N, Rosas-López A, Rosas-Arzate G, Armengolt-Jiménez A, Aguayo A, López-Karpovitch X, Crespo-Solís E.

Rev Invest Clin. 2008 Nov-Dec;60(6):459-69. Spanish. Erratum in: Rev Invest Clin. 2009 Jan-Feb;61(1):90.

PMID:
19378832
14.

Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult patients with acute lymphoblastic leukemia: the ALL-87 study of the Japan Adult Leukemia Study Group (JALSG).

Tanimoto M, Miyawaki S, Ino T, Kyo T, Sakamaki H, Naoe T, Hiraoka A, Asou N, Ohshima T, Tsubaki K, Kuriyama K, Ueda T, Minamil S, Okabe K, Saito H, Murakami H, Hirano M, Dohy H, Onozawa Y, Suzuki H, Ohno R.

Int J Hematol. 1998 Dec;68(4):421-9.

PMID:
9885441
15.

Response rate of Pakistani children with acute lymphoblastic leukaemia to Medical Research Council acute lymphoblastic leukaemia 97 chemotherapy protocol.

Idris M, Farid J, Sarwar J, Ahmed S, Wiqar MA, Badsha S.

J Ayub Med Coll Abbottabad. 2010 Jul-Sep;22(3):8-11.

PMID:
22338406
16.

Acute lymphoblastic leukemia in young adults: two chemotherapeutic protocols for the treatment of 46 patients.

Ho CL, Chen YC, Kao WY, Chao TY.

Zhonghua Yi Xue Za Zhi (Taipei). 2000 Jan;63(1):45-52.

PMID:
10645050
17.

Treatment of acute lymphoblastic leukaemia (ALL).

Jacobs P, Wood L.

Eur J Haematol. 1992 Aug;49(2):53-8.

PMID:
1397240
18.

A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.

Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Schulman P, Duggan D, Davey FR, Sobol RE, Frankel SR, et al.

Blood. 1995 Apr 15;85(8):2025-37.

19.

[Clinical characteristics and outcomes of 59 patients with acute lymphoblastic leukemia positive for BCR/ABL].

Liu Z, Liu XL, Du QF, Xu N, Zhong M, Song LL, Yi ZS, Liu QF, Meng FY, Zhou SY.

Nan Fang Yi Ke Da Xue Xue Bao. 2009 Mar;29(3):512-5. Chinese.

20.

[Acute lymphoblastic leukemia in adults. Apropos of 42 cases].

Laatiri MA, Chehata S, Amouri A, Bouaouina N, Gayed C, Saad A, Ennabli S.

Tunis Med. 2000 Feb;78(2):115-9. French.

PMID:
10894047

Supplemental Content

Support Center